BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 1565898)

  • 21. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE; Leibovich BC; Lohse CM; Kwon ED; Zincke H; Blute ML
    J Urol; 2006 Nov; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Conservative surgery for renal carcinoma].
    González Martín M; Alvarez Castelo LM; Chantada Abal V; Rodríguez-Rivera J; Sánchez Merino JM; Gómez Veiga F
    Actas Urol Esp; 1999 May; 23(5):424-31. PubMed ID: 10427817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nephron-sparing surgery for renal tumor: a choice of treatment in an allograft kidney.
    Ribal MJ; Rodriguez F; Musquera M; Segarra J; Guirado L; Villavicencio H; Alcaraz A
    Transplant Proc; 2006 Jun; 38(5):1359-62. PubMed ID: 16797303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
    Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
    Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal-sparing surgery for renal cell carcinoma.
    Novick AC
    Urol Clin North Am; 1993 May; 20(2):277-82. PubMed ID: 8493750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progression and long-term survival after simple enucleation for the elective treatment of renal cell carcinoma: experience in 107 patients.
    Lapini A; Serni S; Minervini A; Masieri L; Carini M
    J Urol; 2005 Jul; 174(1):57-60; discussion 60. PubMed ID: 15947577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open surgical partial nephrectomy.
    Ghavamian R; Zincke H
    Semin Urol Oncol; 2001 May; 19(2):103-13. PubMed ID: 11354530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The indications for partial nephrectomy in the treatment of renal cell carcinoma.
    Joniau S; Vander Eeckt K; Van Poppel H
    Nat Clin Pract Urol; 2006 Apr; 3(4):198-205. PubMed ID: 16607368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Choice of operation for clinically localized renal tumor.
    Nguyen CT; Campbell SC; Novick AC
    Urol Clin North Am; 2008 Nov; 35(4):645-55; vii. PubMed ID: 18992618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parenchyma-conserving surgery for renal cell carcinoma.
    Taari K; Salo JO; Rannikko S; Kärkkäinen P; Nordling S; Lehtonen T
    Ann Chir Gynaecol Suppl; 1993; 206():54-8. PubMed ID: 8291871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of local recurrence following radical nephrectomy or partial nephrectomy.
    Campbell SC; Novick AC
    Urol Clin North Am; 1994 Nov; 21(4):593-9. PubMed ID: 7974892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nephron-sparing surgery for localized kidney neoplasms--a report of 25 cases].
    Li YH; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Yu SL; Wang H
    Ai Zheng; 2006 Jan; 25(1):76-9. PubMed ID: 16405755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.
    Hafez KS; Novick AC; Campbell SC
    J Urol; 1997 Jun; 157(6):2067-70. PubMed ID: 9146581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
    Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
    J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
    Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
    Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
    Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
    BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience.
    Herring JC; Enquist EG; Chernoff A; Linehan WM; Choyke PL; Walther MM
    J Urol; 2001 Mar; 165(3):777-81. PubMed ID: 11176466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.